SERENACE Side Effects

6723185-0 | Dystonia, Overdose, Product Name Confusion
on May 04, 2010 Male patient from INDIA , child 5 years of age, weighting 33.07 lb, was treated with Serenace (View Usage). Patient experienced the following unwanted or unexpected effects: dystonia (What is dystonia?), overdose, product name confusion. Serenace dosage: . During the same period patient was treated with SERRONAK (View Serronak Review and Serronak Label ).

4742893-4 | Activities Of Daily Living Impaired, Anxiety, Asocial Behaviour, Disturbance In Attention, Hallucination, Motor Dysfunction, Psychiatric Symptom, Schizophrenia
Patient was taking Serenace (View Usage). Patient had the following side effects: activities of daily living impaired, anxiety (What is anxiety?), asocial behaviour, disturbance in attention, hallucination, motor dysfunction, psychiatric symptom, schizophrenia on Jun 28, 2005 from AUSTRALIA Additional patient health information: Female patient , 29 years of age, was diagnosed with abnormal behaviour and. Serenace dosage: . During the same period patient was treated with TEGRETOL (100 Mg, Tid) (View Tegretol Review and Tegretol Label ), EPILIM (100 Mg, Qd, At Night) (View Epilim Review and Epilim Label ), MELLARIL (Unk, Unk) (View Mellaril Review and Mellaril Label ).

4730457-8 | Activities Of Daily Living Impaired, Anxiety, Asocial Behaviour, Disturbance In Attention, Hallucination, Motor Dysfunction, Psychiatric Symptom, Schizophrenia
Adverse event was reported on Jun 28, 2005 by a Female patient taking Serenace (View Usage) (Dosage: ) . Location: AUSTRALIA , 29 years of age, After Serenace was administered, patient had the following side effects: activities of daily living impaired, anxiety (What is anxiety?), asocial behaviour, disturbance in attention, hallucination, motor dysfunction, psychiatric symptom, schizophrenia. During the same period patient was treated with TEGRETOL (100 Mg, Tid) (View Tegretol Review and Tegretol Label ), EPILIM (100 Mg, Qd, At Night) (View Epilim Review and Epilim Label ), MELLARIL (Unk, Unk) (View Mellaril Review and Mellaril Label ).

4730415-3 | Activities Of Daily Living Impaired, Anxiety, Asocial Behaviour, Disturbance In Attention, Hallucination, Motor Dysfunction, Psychiatric Symptom, Schizophrenia
on Jun 28, 2005 Female patient from AUSTRALIA , 29 years of age, was treated with Serenace (View Usage). Patient experienced the following unwanted or unexpected effects: activities of daily living impaired, anxiety (What is anxiety?), asocial behaviour, disturbance in attention, hallucination, motor dysfunction, psychiatric symptom, schizophrenia. Serenace dosage: . During the same period patient was treated with TEGRETOL (100 Mg, Tid) (View Tegretol Review and Tegretol Label ), EPILIM (100 Mg, Qd, At Night) (View Epilim Review and Epilim Label ), MELLARIL (Unk, Unk) (View Mellaril Review and Mellaril Label ).


4724211-0 | Neuroleptic Malignant Syndrome
on Jan 07, 2005 Male patient from JAPAN , 67 years of age, was diagnosed with delusion, hallucination, depression (What is depression?), insomnia and was treated with Serenace (View Usage). Patient had the following side effects: neuroleptic malignant syndrome. Serenace dosage: 2.25 Mg/d. During the same period patient was treated with DEPROMEL (75 Mg/d) (View Depromel Review and Depromel Label ), DEPAS (1.5 Mg/d) (View Depas Review and Depas Label ), TASMOLIN (3 To 6 Mg/d) (View Tasmolin Review and Tasmolin Label ), LUDIOMIL (25 Mg/d) (View Ludiomil Review and Ludiomil Label ), TETRAMIDE (30 Mg/d) (View Tetramide Review and Tetramide Label ), BENZALIN (5 To 10 Mg/d) (View Benzalin Review and Benzalin Label ).

4598333-1 | Neuroleptic Malignant Syndrome
Patient was taking Serenace (View Usage). After Serenace was administered, patient had the following side effects: neuroleptic malignant syndrome on Jan 07, 2005 from Additional patient health information: Male patient , 67 years of age, was diagnosed with delusion, hallucination, depression (What is depression?), insomnia and. Serenace dosage: 2.25 Mg/d. During the same period patient was treated with DEPROMEL (75 Mg/d) (View Depromel Review and Depromel Label ), DEPAS (1.5 Mg/d) (View Depas Review and Depas Label ), TASMOLIN (3 To 6 Mg/d) (View Tasmolin Review and Tasmolin Label ), LUDIOMIL (25 Mg/d) (View Ludiomil Review and Ludiomil Label ), TETRAMIDE (30 Mg/d) (View Tetramide Review and Tetramide Label ), BENZALIN (5 To 10 Mg/d) (View Benzalin Review and Benzalin Label ).

4576017-3 | Asthenia, Bladder Catheterisation, Blood Creatine Phosphokinase Increased, Blood Pressure Increased, Body Temperature Increased, Depressed Level Of Consciousness, Feeling Hot, Heart Rate Increased
Adverse event was reported on Jan 07, 2005 by a Female patient taking Serenace (View Usage) (Dosage: 3 Mg/day) was diagnosed with schizophrenia, nail tinea and. Location: , 69 years of age, weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: asthenia, bladder catheterisation, blood creatine phosphokinase increased, blood pressure increased, body temperature increased, depressed level of consciousness, feeling hot, heart rate increased. During the same period patient was treated with MELLARIL (75 Mg/day) (View Mellaril Review and Mellaril Label ), LAMISIL (125 Mg, Qd) (View Lamisil Review and Lamisil Label ). Patient was hospitalized.

4564997-1 | Asthenia, Bladder Catheterisation, Blood Creatine Phosphokinase Increased, Blood Pressure Increased, Body Temperature Increased, Depressed Level Of Consciousness, Feeling Hot, Heart Rate Increased
on Jan 07, 2005 Female patient from , 69 years of age, weighting 143.3 lb, was diagnosed with schizophrenia, nail tinea and was treated with Serenace (View Usage). Patient had the following side effects: asthenia, bladder catheterisation, blood creatine phosphokinase increased, blood pressure increased, body temperature increased, depressed level of consciousness, feeling hot, heart rate increased. Serenace dosage: 3 Mg/day. During the same period patient was treated with MELLARIL (75 Mg/day) (View Mellaril Review and Mellaril Label ), LAMISIL (125 Mg, Qd) (View Lamisil Review and Lamisil Label ). Patient was hospitalized.

4555685-6 | Blood Pressure Increased, Caesarean Section, Excitability, Foetal Distress Syndrome, Foetal Heart Rate Abnormal, Insomnia, Spinal Anaesthesia
on Dec 22, 2004 Female patient from , 38 years of age, was diagnosed with pre-eclampsia and was treated with Serenace (View Usage). After Serenace was administered, patient had the following side effects: blood pressure increased, caesarean section, excitability, foetal distress syndrome, foetal heart rate abnormal, insomnia, spinal anaesthesia. Serenace dosage: . During the same period patient was treated with AKINETON (View Akineton Review and Akineton Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ).

4550983-4 | Blood Creatine Phosphokinase Increased, Malaise, Rhabdomyolysis
Patient was taking Serenace (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, malaise, rhabdomyolysis on Jan 07, 2005 from Additional patient health information: Female patient , 60 years of age, was diagnosed with schizophrenia, fungal skin infection and. Serenace dosage: 3 Mg/d. During the same period patient was treated with MELLERIL (30 Mg/d) (View Melleril Review and Melleril Label ), LAMISIL (125 Mg, Qd) (View Lamisil Review and Lamisil Label ).